Conventional, CT and MR imaging technologies are limited in their availability, to depict soft tissue, or to show dynamic activity, like cardiac muscle contractility and blood flow. Easy applicability, real-time sonography and biopsy facilitation are important advantages in veterinarian medicine. Veterinary ultrasound has a very high sensitivity to show the composition of soft tissues, but the low specificity is a disadvantage. High ultrasound system performance includes Doppler techniques, contrast enhanced ultrasound, 3D ultrasound, and tissue harmonic imaging to improve resolution.
Technical and physical requirements of veterinary ultrasound are the same as in human ultrasonography. The higher the sound frequency, the better the possible resolution, but the poorer the tissue penetration. Image quality is depended of the ultrasound equipment. For example, a 10 MHz transducer is excellent for imaging of superficial structures; a 3.5 or 5.0 megahertz transducer allows sufficient penetration to see inner structures like the liver or the heart. In addition, the preparation and performing of the examination is similar to that of humans. The sound beam penetrates soft tissue and fat well, but gas and bone impede the ultrasonic power. Fluid filled organs like the bladder are often used as an acoustic window, and an ultrasound gel is used to conduct the sound beam.

The usual applications of endocavitary echography (also called internal echography / endoscopic ultrasound (EUS)) are examinations of the pelvic organs through internally introduced probes, which give a more precise and correct image.
Transrectal ultrasound is a well established method for rectal or prostate carcinoma assessment.
A transvaginal echography uses a small transducer that is inserted directly into the vagina.
Used are high-frequency (10-12 MHz) for superficial organs, endocavitary echography, and intraoperative laparoscopic ultrasound. A sterile cover is slipped over the probe, which is then covered with lubricating ultrasound gel and placed in the cavitary (see Equipment Preparation).

See also Endoscopic Ultrasound, Prostate Ultrasound, Interventional Ultrasound, Transurethral Sonography, Vaginal Probe, Rectal Probe.

Ultrasound technology with its advancements is vital for delivering high-quality patient care. Innovations including high-frequency ultrasound, 3D//4D imaging, contrast enhanced ultrasound, elastography, and point-of-care ultrasound, have expanded the capabilities of ultrasound imaging and improved diagnostic accuracy.
B-Mode imaging, also known as brightness mode, is the fundamental technique in ultrasound imaging. It produces two-dimensional images based on the echoes received from tissues and organs. Understanding the principles of B-Mode imaging, such as gain adjustment, depth control, and image optimization, is crucial for obtaining diagnostically valuable images. M-Mode imaging, on the other hand, allows for the visualization of motion over time, enabling assessment of cardiac structures and function, as well as fetal heart rate.
High-frequency ultrasound refers to the use of ultrasound waves with frequencies greater than 10 MHz. This technology enables improved resolution, allowing for detailed imaging of superficial structures like skin, tendons, and small organs. High-frequency ultrasound has found applications in dermatology, ophthalmology, and musculoskeletal imaging.
Traditional 2D ultrasound has been augmented by the advent of 3D ultrasound technology. By acquiring multiple 2D images from different angles, this technique construct a volumetric representation of the imaged area. The addition of 4D ultrasound in real-time motion adds further value by capturing dynamic processes.
Doppler imaging employs the Doppler effect to evaluate blood flow within vessels and assess hemodynamics. Color Doppler assigns color to different blood flow velocities, providing a visual representation of blood flow direction and speed. Spectral Doppler displays blood flow velocities as a waveform, allowing for detailed analysis of flow patterns, resistance, and stenosis.
Contrast enhanced ultrasound employs microbubble contrast agents to enhance the visualization of blood flow and tissue perfusion. By injecting these agents intravenously, sonographers can differentiate between vascular structures and lesions. Elastography is a technique that measures tissue elasticity or stiffness. It assists in differentiating between normal and abnormal tissues, aiding in the diagnosis of various conditions such as liver fibrosis, breast lesions, and thyroid nodules.
Fusion imaging combines ultrasound with other imaging modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET). By overlaying or merging ultrasound images with those obtained from other modalities, the user can precisely locate and characterize abnormalities, guide interventions, and improve diagnostic accuracy. Fusion imaging has proven particularly useful in areas such as interventional radiology, oncology, and urology.
See also Equipment Preparation, Environmental Protection, Handheld Ultrasound, Portable Ultrasound and Ultrasound Accessories and Supplies.

'ALOKA, the innovator in ultrasound is the longest operating ultrasound company in the world with its main headquarters located in Tokyo, Japan.
The history of ALOKA began in 1950 when the medical equipment department of Japan Radio Company became the independent company, Medical and Physical Institute Co., Ltd.
In 1960, we developed the world's first commercially available diagnostic ultrasound system.
In 1976, our company name changed to ALOKA, which, in ancient Sanskrit, means 'Ray of Hope'.
ALOKA's ultrasound systems have been sold in the United States through distributors since the early 70s. Some of our major distributors included Johnson & Johnson Ultrasound and Corometrics Medical Systems, Inc., which also provided service for the ALOKA equipment.
In 1986 the first ALOKA office was opened in the United States.
And on January 1, 1991, ALOKA America began direct sales of ultrasound units.
All US sales, distribution and service are provided through our US headquarters located in Wallingford, Connecticut . In addition, we have sales, service and clinical applications representatives strategically located throughout the country to provide exceptional service to our customers.'

In November 2010 Hitachi Medical announced the acquisition of ALOKA.

Ultrasound Systems:

'During the 60 years since our establishment, Fukuda Denshi Co., Ltd has been involved in the development and sales for Medical Equipment in the Cardiovascular field. The history of Fukuda Denshi Co., Ltd is the history of the Electrocardiograph. From the first Electrocardiograph in Japan until now, a history of our innovations is listed.'

Ultrasound Systems: